Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7865]

FDA grants accelerated approval to mobocertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations

FDA grants accelerated approval to mobocertinib for metastatic non-small cell lung cancer with EGFR exon 20...

ESMO 21: Patients and non-oncology doctors struggle to keep up with the pace of change in oncology, research shows

ESMO 21: Patients and non-oncology doctors struggle to keep up with the pace of change in oncology, research shows

Changing the fate: Converting glioma cells into neurones may treat glioblastoma

Changing the fate: Converting glioma cells into neurones may treat glioblastoma

Improving leukaemia therapy with targeted treatment approaches

Improving leukaemia therapy with targeted treatment approaches

Researchers discover a dependency of glioblastoma on biotin distribution

Researchers discover a dependency of glioblastoma on biotin distribution

Scientists discover new pathway that prevents bowel cancer treatment from working

Scientists discover new pathway that prevents bowel cancer treatment from working

Immunotherapy after high-dose chemotherapy leads to favorable outcomes in acute myeloid leukaemia

Immunotherapy after high-dose chemotherapy leads to favorable outcomes in acute myeloid leukaemia

WCLC 2021: Durvalumab and tremelimumab with chemo improved PFS and OS in 1st-line stage IV NSCLC vs chemo

WCLC 2021: Durvalumab and tremelimumab with chemo improved PFS and OS in 1st-line stage IV NSCLC vs chemo

KRAS G12C inhibitor sotorasib receives conditional marketing authorisation by MHRA for use in Great Britain

KRAS G12C inhibitor sotorasib receives conditional marketing authorisation by MHRA for use in Great Britain

FDA approves zanubrutinib for Waldenström’s macroglobulinemia

FDA approves zanubrutinib for Waldenström’s macroglobulinemia

More from ecancer